期刊文献+

高效液相色谱-质谱法测定伪麻黄碱血药浓度 被引量:2

Determination of Pseudoephedrine in Human Plasma by HPLC-MS
下载PDF
导出
摘要 目的建立高效液相色谱-质谱(HPLC-MS)法测定伪麻黄酸碱的血药浓度。方法将血浆样品采用甲醇沉淀后,以格列吡嗪为内标进行测定。色谱柱为Agilent Zorbax SB-C18柱(150mm×4.6mm,5μm),流动相为5mmol/L醋酸铵-甲醇(10∶90,V/V),流速为1.0mL/min,离子检测方式设为选择性离子检测(SIM),检测离子极性为正离子,采用气动辅助电喷雾离子化(ESI)方式,检测对象为伪麻黄碱(M+H离子,m/z148.4),内标格列吡嗪(M+Na离子,m/z468.1)。结果线性范围为5.01~1002μg/L(r=0.9997),最低检测限为5μg/L。方法回收率为89.6%~95.1%,日内、日间精密度RSD分别小于5.2%和7.1%。结论该方法选择性好,灵敏度高,简便易行,适用于伪麻黄碱药代动力学和生物等效性研究。 Objective To establish HPLC- MS method for determination of pseudoephedrine in human plasma. Methods The extraction solvent was methanol. Liquid-liquid extraction was used to treat with human plasma. Agitent Zorbax SB-C18 (150 mm×4.6 mm, 5 μm) column was used with methanol - 5 mmot/L ammonium acetate water solution (90 : 10, V/ V) as the mobile phase and a flow rate of 1.0 mL/min. A Waters ZQ 2000 HPLC- MS system with an atmospheric pressure chemical ionization (APCI) source was used as the detector and was operated in a positive ion mode. Selected ion monitoring (SIM)was performed and the m/z of ions selected for quantification were 148.4 (pseudoephedrine) and m/z 468. 1 (internal standard, gtipizide). Results Calibration curve for pseudoephedrine was linear over the range of 5.01- 1 002 μg/L. The lowest limit of quantitation was 5 μg/L. The method recovery rates were 89,6%-95. 1%.The inter and intra day precisions were less than 5.2% and 7. 1%. Conclusion The method was proved to be sensitive, accurate and convenient. It can be applied to study the pharmacokinetics of pseudoephedrine in human plasma.
出处 《中国药业》 CAS 2007年第19期4-5,共2页 China Pharmaceuticals
关键词 伪麻黄碱 高效液相色谱-质谱法 血药浓度 pseudoephedrine HPLC - MS plasma concentration
  • 相关文献

参考文献5

二级参考文献7

共引文献39

同被引文献32

  • 1Mansfield LE.Once-daily immediate-release fexofenadine and sustained-release pseudoephedrine combination:a new treatment option for allergic rhinitis[J].Exp Opin Pharmacother,2006,7(7): 941-951.
  • 2Miura M,Uno T, Tateishi T, et al.Determination of fexofenadine enantiomers in human plasma with high performance liquid chromatography[J].J Pharm Biomed Anal,2007,43(2):741-745.
  • 3Ma L,Yin L,Sun J,et al.A sensitive high-performance liquid chromatography coupled with solid-phase extraction for deter- mination of fexofenadine in beagle plasma[J].J Chinese Pharm Sci,2005,14(4):246-249.
  • 4Robbins DK, Castles MA,Pack DJ,et al.Dose proportionality and comparison of single and multiple dose pharmacokinetics of fexofenadine (MDL 16455)'and its enantiomers in healthy male volunteers[J].Biopharm Drug Disposition, 1998,19(7): 455-563.
  • 5Uno T,Yasui-Furukori N,Takahata T, et al.Liquid chromatographic determination of fexofenadine in human plasma with fluorescence detection[J].J Pharm Biomed Anal,2004,35(4):937-942.
  • 6Pathak SM,Kumar AR,Musmade P, et al.A simple and rapid high performance liquid chromatographic method with fluorescence detection for the estimation of fexofenadine in rat plasma-appli- cation to preclinical pharmacokinetics [J].Talanta,2008,76(2): 338-346.
  • 7Hotinann U,Seiler M,Drescher S,et al.Determinatlon of texolena- dine in human plasma and urine by liquid chromatography-mass spectrometry[J].J Chromatogr B Analyt Technol Biomed Life Sci, 2002,766(2):227-233.
  • 8Isleyen EAO,Ozden T, Ozilhan S,et al.Quantitative determination of fexofenadine in human plasma by HPLC-MS[J].Chromatograp hia,2007,66(S 1): 109-113.
  • 9Nirogi RV, Kandikere VN,Shukla M,et al.Quantification of fexof- enadine in human plasma by liquid chromatography coupled to electrospray tandem mass spectrometry using mosapride as internal standard[J].Biomed Chromatogr,2007,21 (2):209-216.
  • 10Naoe Y, Zenzaburou T, Yuichi S,et al.Microdose clinical trial: Quantitative determination of fexofenadine in human plasma using liquid chromatography/electrospray ionization tandem mass spectrometry[J].J Chromatography B,2007,858(1): 118-128.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部